Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT00710580 · COMPLETED
Trial details
- NCT number
- NCT00710580
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2009-04-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.